Ledger.Open graph →
SEC Form D · filed July 22, 2022

Annexon, Inc

Offering
$130.5M
Sold
$130.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Brisbane, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Muneer A. Satter · New York, NYDirectorWilliam D. Waddill · Redwood City, CADirectorThomas G. Wiggans · Solana Beach, CADirectorMichael C. Overdorf · Brisbane, CAExecLarry C. Mattheakis, Ph.D · Brisbane, CAExecDouglas Love · So. San Francisco, CAExec · DirectorJennifer Lew · South San Francisco, CAExecBettina M. Cockroft, M.D · Brisbane, CADirectorWilliam H. Carson, M.D · Brisbane, CADirectorJung E. Choi · South San Francisco, CADirectorWilliam D. Waddill · Brisbane, CADirectorThomas G. Wiggans · MENLO PARK, CADirectorMuneer A. Satter · South San Francisco, CADirectorMichael C. Overdorf · Brisbane, CAExecLarry C. Mattheakis, Ph.D · Brisbane, CAExecDouglas Love · So. San Francisco, CAExec · DirectorJennifer Lew · South San Francisco, CAExecBettina M. Cockroft, M.D · Brisbane, CADirectorWilliam H. Carson, M.D · Brisbane, CADirectorJung E. Choi · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗